Neoadjuvant Erbitux Based Chemotherapy for Locally Advanced Oral/Oropharyngeal Cancer

NCT01434394 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

243

Enrollment

OTHER

Sponsor class

Conditions

Locally Advanced Malignant Neoplasm
Oral Cancer
Oropharyngeal Carcinoma
Effects of Chemotherapy

Interventions

DRUG: Neo-adjuvant Erbitux-based chemotherapy

Sponsor

Shanghai Jiao Tong University School of Medicine

Collaborators

[object Object]
[object Object]
[object Object]